ALB Albemarle Corporation

8-K Current Report

Filed: March 4, 2026

Health Care

Plastic Materials, Synth Resins & Nonvulcan Elastomers

Albemarle Corporation (ALB) 8-K current report filed with SEC EDGAR on March 4, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 5.02: Departure/Election of Directors or Officers
Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• Two new independent directors appointed Feb 26, 2026: Michelle T. Collins and Mark R. Widmar
• Collins joins Audit & Finance + Governance committees; Widmar joins Exec Compensation + Safety/Operations committees

+3 more insights

Item 7.01 · Regulation FD Disclosure

• Press release announcing executive appointments issued March 2, 2026, furnished as Exhibit 99.1
• Reg FD disclosure ensures simultaneous public access to leadership change information — material for investors tracking management transitions at ALB

Other Albemarle Corporation 8-K Filings

8-K Mar 6, 2026

Get deeper insights on Albemarle Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.